EMEA-002532-PIP01-18-M02
Key facts
Active substance |
Phenobarbital
|
Therapeutic area |
Neurology
|
Decision number |
P/0301/2021
|
PIP number |
EMEA-002532-PIP01-18-M02
|
Pharmaceutical form(s) |
Oral suspension
|
Condition(s) / indication(s) |
Treatment of epilepsy
|
Route(s) of administration |
|
Contact for public enquiries |
Proveca Pharma Limited
+44 (0)1614 682627 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|